Latest News
Warwick scientists design model to predict cellular drug targets against Covid-19
A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce by researchers at the University of Warwick. This study helps understand how the virus uses the host to survive, and enable drug predictions for treating the virus to be made.
Migrant Leaders founder to speak on inclusion in professional world – EUTOPIA Week
The Founder and CEO of Migrant Leaders — a charity that helps disadvantaged young people from all backgrounds to access and succeed within the professional world — will be speaking to students from across Europe as part of EUTOPIA Week, hosted by the University of Warwick, her alma mater.
Diabetic drug could slow the progression of Parkinson’s disease
· A hallmark of Parkinson's disease is the degeneration of a group of neurons in the brain that release the neurotransmitter dopamine (dopaminergic neurons). By introducing low concentrations of structurally-defined aggregates of alpha synuclein, a key toxic species in Parkinson’s disease, into single dopaminergic neurons, researchers from the University of Warwick have shown these protein aggregates open a specific channel in the cell membrane, reducing neuronal excitability. Furthermore they’ve shown that this can be partially prevented by pre-application of the commonly used anti-diabetic drug, glibenclamide.
New engineering partnership to develop digital marketplace to improve manufacturing supply chain
A research team, including WMG at the University of Warwick, led by Swansea University College of Engineering, are developing a pilot online marketplace designed to optimise manufacturing supply chain networks and create a new industry-wide business model.
LGBT+ in lockdown? Share your perspective with Queer/Disrupt
Queer/Disrupt, a student-led research collective based at the University of Warwick, wants LGBT+ creators and allies to submit their work for a new exhibition and permanent archive on the theme of “Queering the Quarantine.”
Breakthrough in studying the enzyme that ultimately produces fish odour syndrome
Fish odour syndrome (trimethylaminuria) is a debilitating disease, in which the liver cannot break down the smelly chemical trimethylamine which is produced by enzymes from bacteria residing in the gut leaving people with a fish like odour. Researchers from the University of Warwick are paving the way to prevent the syndrome after a breakthrough in studying the enzyme in the gut which produces trimethylamine.